A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute (NCI)
Grant: R01CA193776 (DTT)
National Cancer Institute (NCI)
Grant: R01CA264837 (DTT)
National Cancer Institute (NCI)
Grant: X01HD100702-01 (DTT)
National Cancer Institute (NCI)
Grant: R03CA256550 (DTT)
National Cancer Institute (NCI)
Grant: UG1CA233249 (DTT)
National Cancer Institute (NCI)
Grant: 5T32CA009615
NCI NIH HHS
Grant: R01 CA264837
NCI NIH HHS
Grant: R01 CA193776
NCI NIH HHS
Grant: R03 CA256550
NCI NIH HHS
Grant: UG1 CA233249
NCI NIH HHS
Grant: T32 CA009615
National Institutes of Health
Grant: 1R03CA256550-01
Genomic Profiling of T-cell Acute Lymphoblastic Leukemia in Children
National Institutes of Health
Grant: 5T32CA009615-24
Cancer Center Research Training Program
National Institutes of Health
Grant: 5R01CA264837-04
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
National Institutes of Health
Grant: 5UG1CA233249-02
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children
National Institutes of Health
Grant: 5R01CA193776-05
Improving risk allocation and developing novel therapies for children with T-ALL
Children’s Oncology Group
Alex’s Lemonade Stand Foundation for Childhood Cancer
Leukemia and Lymphoma Society
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals